搜索结果: 1-15 共查到“肿瘤学 lung cancer”相关记录33条 . 查询时间(0.109 秒)
Data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer（图）
晚期肺癌 免疫治疗 停止治疗
2023/6/27
Over the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment for patients with advanced lung cancer, helping many live longer lives and improving overall survival fo...
Immunotherapy — drug treatment that stimulates the immune system to attack tumors — works well against some types of cancer, but it has shown mixed success against lung cancer.
Lung cancer screening: Summary of the evidence and the 2013 US Preventative Services Task Force recommendations
Lung cancer screening Summary of the evidence the 2013 US Preventative Services Task Force
2015/4/17
The United States Preventative Services Task Force is an independent panel of non-Federal experts in prevention and evidence-based medicine that reviews scientific studies and makes recommendations on...
Lung cancer
Lung cancer surgery
2015/4/8
Almost untreatable in 1973, except by surgery, lung cancer is now susceptible to radiotherapy and chemotherapy as
well, and is often treated by all three modalities in combination. Although tobacco ...
Evolution of biological therapies in non-small cell lung cancer
biological therapies non-small cell lung cancer
2015/3/26
This article explores recent clinical developments of biological or targeted therapies in non-small cell lung cancer. Molecular research has given us a greater understanding of tumour biology and has ...
Non-small cell lung cancer in the elderly - systemic therapy
Non-small cell lung cancer elderly - systemic therapy
2015/3/26
Elderly patients represent a significant and rising proportion of patients with Non-Small Cell Lung Cancer and historically they have been under-treated and under-represented in clinical trials. Incre...
A technique which can detect a growing pulmonary malignancy when it is small should allow more effective therapy and a better outcome for patients. Henschke and her colleagues in the Early Lung Cancer...
FDG PET: Revolution or evolution in the management of non-small cell lung cancer?
Revolution evolution management of non-small cell lung cancer
2015/3/11
Lung cancer is currently the leading cause of cancer-related death in both men and women in most Western countries. In Australia there is a falling incidence in males that is not matched in females, t...
Contemporary management of non-small cell lung cancer in Australia
Contemporary management non-small cell lung cancer Australia
2015/3/11
In 1955, Bromley and Szur reported on 66 patients with a pathologic diagnosis of lung cancer who had been treated with high dose radiotherapy and who had then proceeded to surgery1. In 24 (46.7%) no t...
Systemic therapy of lung cancer: where are we in 2002?
Systemic therapy lung cancer where are we in 2002
2015/3/11
At a time when our understanding of the molecular biology of cancer was supposed to lead to major advances in therapy, it is disappointing to report that the major lung cancer ‘story’ of 2002 (table o...
As the biggest cause of cancer death in the Western world, lung cancer is frequently encountered in the day-to-day practice of adult thoracic physicians. The vast explosion of knowledge, ranging from ...
Researchers discover new genetic anomalies in lung cancer（图）
new genetic anomalies lung cancer
2014/12/30
By analyzing the DNA and RNA of lung cancers, researchers at the University of Michigan Comprehensive Cancer Center found that patients whose tumors contained a large number of gene fusions had worse ...
Sleep Duration and Risk of Lung Cancer in the Physicians' Health Study
Sleep Duration Risk Lung Cancer Physicians' Health Study
2014/9/29
Background and Objectives: Lung cancer is the most common cancer and cancer related cause of death worldwide. However, the association between sleep duration and incident lung cancer has not been inve...
RNA combination therapy for lung cancer offers promise for personalized medicine（图）
lung cancer personalized medicine RNA
2014/8/19
Small RNA molecules, including microRNAs (miRNAs) and small interfering RNAs (siRNAs), offer tremendous potential as new therapeutic agents to inhibit cancer-cell growth. However, delivering these sma...
RNA combination therapy for lung cancer offers promise for personalized medicine（图）
lung cancer personalized medicine RNA
2014/8/19
Small RNA molecules, including microRNAs (miRNAs) and small interfering RNAs (siRNAs), offer tremendous potential as new therapeutic agents to inhibit cancer-cell growth. However, delivering these sma...